Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-01-19 | Acumen Pharmaceuticals, Inc. | OConnell Daniel J...
(President and CEO) |
S | Common Stock | D | 15200 | $3.47 - $3.47 | $52,753 |
2024-01-19 | Acumen Pharmaceuticals, Inc. | Meisner Derek M
(Chief Legal Officer & Corp Sec) |
S | Common Stock | D | 8933 | $3.48 - $3.48 | $31,048 |
2024-01-18 | Acumen Pharmaceuticals, Inc. | Zuga Matt
(CFO & Chief Business Officer) |
S | Common Stock | D | 4242 | $3.71 - $3.71 | $15,716 |
2024-01-18 | Acumen Pharmaceuticals, Inc. | Siemers Eric
(Chief Medical Officer) |
S | Common Stock | D | 3124 | $3.71 - $3.71 | $11,603 |
2024-01-18 | Acumen Pharmaceuticals, Inc. | Barton Russell
(Chief Operating Officer) |
S | Common Stock | D | 2833 | $3.73 - $3.73 | $10,555 |
2024-01-02 | Acumen Pharmaceuticals, Inc. | Zuga Matt
(CFO & Chief Business Officer) |
A | Common Stock | A | 106000 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |